Global Clostridium Difficile Treatment Market 2017-2021

Global Clostridium Difficile Treatment Market 2017-2021

Jun 2017 Technavio Infectious Disease70 Pages Price :
$ 3500
About Clostridium Defficile Treatment
CDI is a bacterium that can cause symptoms such as diarrhea and life-threatening inflammation of the colon. CDI mostly affects elderly people who frequent hospitals or people who live in long-term care facilities. CDI can also occur due to the prolonged use of antibiotics. The first line of treatment for CDI is antibiotics.
Technavios analysts forecast the global clostridium defficile treatment market to grow at a CAGR of 5.14% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global clostridium defficile treatment market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.
The market is divided into the following segments based on geography:
Technavio's report, Global Clostridium Defficile Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Actelion Pharmaceuticals
Summit Therapeutics
Other prominent vendors
Astellas Pharma
Da Volterra
MGB Biopharma
Otsuka Pharmaceutical
Romark Laboratories
Sanofi Pasteur
Seres Therapeutics
Synthetic Biologics
Valeant Pharmaceuticals
Market driver
Rise in aging population
For a full, detailed list, view our report
Market challenge
High cost of therapy and high mortality rate
For a full, detailed list, view our report
Market trend
Special designation
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: Pipeline landscape
PART 06: Market landscape
Market size and forecast
Five forces analysis
PART 07: Market segmentation by drug category
Narrow spectrum antibiotic
Broad spectrum antibiotics
PART 08: Geographical segmentation
PART 09: Decision framework
PART 10: Drivers and challenges
Market drivers
Market challenges
PART 11: Market trends
Emergence of vaccines
Special designation
Drug candidates with strong MOA
PART 12: Vendor landscape
Competitive scenario
PART 13: Key vendor analysis
Actelion Pharmaceuticals
Summit Therapeutics
Other prominent vendors
PART 14: Appendix
List of abbreviations

List of Exhibits
Exhibit 01: CDI: Symptoms
Exhibit 02: Various causes of CDI
Exhibit 03: Global CDI treatment market: Key pipeline molecules by vendors 2016
Exhibit 04: Key clinical trials
Exhibit 05: Global CDI treatment market: Overview
Exhibit 06: Global CDI treatment market 2016-2021 ($ million)
Exhibit 07: Five forces analysis
Exhibit 08: Global CDI treatment market: Segmentation by drug category 2016
Exhibit 09: Global CDI narrow spectrum antibiotics market 2016-2021 ($ million)
Exhibit 10: Global CDI broad spectrum antibiotics market 2016-2021 ($ million)
Exhibit 11: Global CDI treatment market: Segmentation by geography 2016 and 2021 (% share)
Exhibit 12: Global CDI treatment market: Revenue by geography 2016-2021 ($ million)
Exhibit 13: Americas: Overview
Exhibit 14: CDI treatment market in Americas 2016-2021 ($ million)
Exhibit 15: EMEA: Overview
Exhibit 16: CDI treatment market in EMEA 2016-2021 ($ million)
Exhibit 17: APAC: Overview
Exhibit 18: CDI treatment market in APAC 2016-2021 ($ million)
Exhibit 19: Drugs under development
Exhibit 20: Vaccines in development stage
Exhibit 21: Companies that have benefited from special designations
Exhibit 22: Global CDI treatment market: Competitive structure analysis 2016
Exhibit 23: Global CDI treatment market: Strategic success factors of companies
Exhibit 24: Actelion: Key highlights
Exhibit 25: Actelion: Strength assessment
Exhibit 26: Actelion: Strategy assessment
Exhibit 27: Actelion: Opportunity assessment
Exhibit 28: Merck: Key highlights
Exhibit 29: Merck: Strength assessment
Exhibit 30: Merck: Strategy assessment
Exhibit 31: Merck: Opportunity assessment
Exhibit 32: Pfizer: Key highlights
Exhibit 33: Pfizer: Strength assessment
Exhibit 34: Pfizer: Strategy assessment
Exhibit 35: Pfizer: Opportunity assessment
Exhibit 36: Summit Therapeutics: Key highlights
Exhibit 37: Summit Therapeutics: Strength assessment
Exhibit 38: Summit Therapeutics: Strategy assessment
Exhibit 39: Summit Therapeutics: Opportunity assessment

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report

Select License Type :

$ 3500
$ 5000

Do you wish to check sample of this report?

Have Query?

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email :

Back To Top